With Monaghan Medical, Safe Nebulizer Therapy is Possible
23 févr. 2021 08h40 HE | Monaghan Medical Corporation
PLATTSBURGH, N.Y., Feb. 23, 2021 (GLOBE NEWSWIRE) -- Monaghan Medical Corporation wants you to know that you can create a safer environment when delivering nebulizer therapy. Nebulizer therapy is a...
InCarda Logo.png
InCarda Therapeutics Raises $30 Million Through First Close of Series C Equity Financing
21 oct. 2020 08h05 HE | InCarda Therapeutics, Inc.
Proceeds to Support Ongoing Clinical Development of InRhythm™, A First-of-its-Kind Inhaled Antiarrhythmic for Treatment of Paroxysmal Atrial Fibrillation (PAF) Positive Phase 2 Data Scheduled for...
fior-markets-logo.jpg
Global Surgical Sealants and Adhesives Market Is Expected to Reach USD 4.34 billion by 2027 : Fior Markets
17 sept. 2020 04h00 HE | Fior Markets
Newark, NJ, Sept. 17, 2020 (GLOBE NEWSWIRE) -- As per the report published by Fior Markets, the global surgical sealants and adhesives market is expected to grow from USD 2.08 billion in 2019 and to...
LIQUIDIA_Logo.jpg
Liquidia Announces Notice of Allowance for U.S. Patent Application Covering Methods of Treating Pulmonary Hypertension with Dry Powder Treprostinil
28 août 2020 07h15 HE | Liquidia Technologies, Inc.
RESEARCH TRIANGLE PARK, N.C., Aug. 28, 2020 (GLOBE NEWSWIRE) -- Liquidia Technologies, Inc. (NASDAQ: LQDA), a late-stage clinical biopharmaceutical company focused on the development and...
LIQUIDIA_Logo.jpg
Liquidia Reports First Quarter 2020 Financial Results and Provides Corporate Update
11 mai 2020 16h01 HE | Liquidia Technologies, Inc.
Received FDA Acceptance of LIQ861 NDA for ReviewReported Final Safety and Tolerability Results for LIQ861 Inspire TrialManagement to Host Webcast and Conference Call Today at 4:30p.m. ET ...
jc_logo.jpg
Surgical quality improvement initiative reduces postoperative pulmonary complications over decade
30 avr. 2020 13h12 HE | The Joint Commission
Study in May 2020 issue of The Joint Commission Journal on Quality and Patient Safety OAKBROOK TERRACE, Ill., April 30, 2020 (GLOBE NEWSWIRE) -- A new study in the May issue of The Joint...
Monaghan Medical Corporation Announces FDA Clearance for New Respiratory Treatment Option
07 janv. 2020 08h40 HE | Monaghan Medical Corporation
PLATTSBURGH, N.Y., Jan. 07, 2020 (GLOBE NEWSWIRE) -- Monaghan Medical Corporation (MMC) today announced the newly approved combination for two of its groundbreaking products—the Aerobika®...
InCarda Logo.png
InCarda Therapeutics Appoints Daniel G. Welch as Executive Chairman of Board of Directors
03 avr. 2019 08h00 HE | InCarda Therapeutics, Inc.
SAN FRANCISCO, April 03, 2019 (GLOBE NEWSWIRE) -- InCarda Therapeutics, Inc. (“InCarda”), a privately-held biopharmaceutical company developing first-of-their-kind inhaled therapies for...
InCarda Logo.png
New Patent Issuances Strengthen InCarda Therapeutics’ Intellectual Property Portfolio Covering Novel Inhaled Cardiovascular Therapies
07 févr. 2019 08h05 HE | InCarda Therapeutics, Inc.
U.S. Patent Broadly Expands Coverage for Inhaled Treatment of Cardiovascular Disease to Include all Class I – IV Antiarrhythmic Drugs Additional U.S. Patent Provides Coverage for Combination of...
BioNebicine Corp. Commences Tests of Nebulizer Device
04 sept. 2018 13h48 HE | BioNebicine Corp.
St. Petersburg, FL, Sept. 04, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioNebicine Corp. (“BioNebicine” or the “Company”) a privately held biotech company, is pleased to announce that it has...